Prognostic factors in phyllodes tumor of the breast: Are immunohistochemical biomarkers useful?

Journal of the Chinese Medical Association

Volumn 67, Issue 1, 2004, Pages 1-2

  Chu, Jan Show ^a  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN ANTIBODY; PROTEIN P53;

ANTIGEN EXPRESSION; AXILLARY LYMPH NODE; BENIGN TUMOR; BREAST TUMOR; CANCER GRADING; CELL CYCLE S PHASE; CORRELATION ANALYSIS; CYSTOSARCOMA PHYLLOIDES; EDITORIAL; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MASTECTOMY; MISSENSE MUTATION; PROGNOSIS; PROTEIN EXPRESSION; TAIWAN; TREATMENT FAILURE; TUMOR CLASSIFICATION; TUMOR RECURRENCE; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PHYLLODES TUMOR; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1542346258     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Rosen PP. Phyllodes tumor. In: Rosen PP. Rosen's breast pathology 2nd ed. Philadelphia: Lippincott-Raven, 2001:176-200.
2. Kuijper A, Buerger H, Simon R, Schaefer KL, Croonen A, Boecker W, et al. Analysis of the progression of fibroepithelial tumors of the breast by PCR-based clonality assay. J Pathol 2002;197:575-81.
3. Shipitz B, Bomstein Y, Stemberg A, Klein E, Tiomkin V, Kaufman A, et al. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features. J Surg Oncol 2002;79: 86-92.
4. Niezabitowski A, Lackowska B, Rys J, Kruczak A, Kowalska T, Mitus J, et al. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Breast Cancer Res Treat 2001;65:77-85.
5. Kleer CG, Giordano TJ, Braun T, Oberman HA. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol 2001; 14:185-90.
6. Gatalica Z, Finkelstein S, Lucio E, Tawfik O, Palazzo J, Hightower B, Eyzaguirre E. p53 protein expression and gene mutation in phyllodes tumors of the breast. Pathol Res Pract 2001;197:183-7.
7. Kocova L, Skalova A, Fakan F, Rousarova M. Phyllodes tumor of the breast: immunohistochemical study of 37 tumors using MIB1 antibody. Pathol Res Pract 1998;194:97-104.
8. Chan YJ, Chen BF, Chang CL, Yang TL, Fan CC. Expression of p53 protein and Ki-67 antigen in phyllodes tumor of breast. J Chin Med Assoc 2004:67:3-8.
9. Chaney A W, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000;89:1502-11.
10. Mangi AA, Smith BL, Gadd MA, Tanabe KK, Ott MI, Souba WW. Surgical management of phyllodes tumors. Arch Surg 1999;134:487-92.